The natural anticancer compound rocaglamide selectively inhibits the G1‐S‐phase transition in cancer cells through the ATM/ATR‐mediated Chk1/2 cell cycle checkpoints

Publisher: John Wiley & Sons Inc

E-ISSN: 1097-0215|134|8|1991-2002

ISSN: 0020-7136

Source: INTERNATIONAL JOURNAL OF CANCER, Vol.134, Iss.8, 2014-04, pp. : 1991-2002

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract